Published Feb 21, 2022

Labcorp Completes Acquisition of Personal Genome Diagnostics

BURLINGTON, N.C.(BUSINESS WIRE)Feb. 21, 2022 Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has closed its acquisition of Personal Genome Diagnostics Inc. (PGDx), a leader in cancer genomics with a portfolio of comprehensive liquid biopsy and tissue-based products.

Click here
to read the full press release on the Labcorp newsroom.